Therapy, technology and care: Towards new standards in Type 1 diabetes management

 

10:25 – 10:30	Welcome and introduction	Catarina Limbert (Portugal)
10:30 – 10:45	Caring for children and young adolescents with T1D	Thomas Danne (Germany)
10:45 – 11:00	Modernizing diabetes care using new metrics	Tadej Battelino (Slovenia)
11:00 – 11:15	Connecting the dots to improve diabetes outcomes	Katharine Barnard-Kelly (UK)
11:15 – 11:25	Q&A and closing remarks

 

This satellite symposium is specifically intended for healthcare professionals (HCPs) and is sponsored by Sanofi on the occasion of the 46th Annual ISPAD Conference, October 15-17, 2020. Content concerning medicinal product(s) is, where applicable, consistent with the European Summary of Product Characteristics (SmPC) for that product. Please consult prescribing information in your country of practice current to date of the first presentation at ISPAD 2020 on Thursday 15 October, in respect to medicinal products mentioned as information may vary from country to country. Products mentioned may not be authorised/licensed or available in all countries worldwide, please check with the Regulatory Authority in your country for further information.

This education program focuses on the importance of treating the whole patient when looking to introduce real-time CGM into their diabetes treatment regimen.  Pediatric patients and families benefit from a multi-disciplinary approach with both their Pediatric Endocrinologist and Behavioral Therapist, especially when assessing the patient’s readiness to start rtCGM, overcoming individual barriers and providing the patient and families with skills for the successful start and ongoing use of this technology.  This education program addresses the psychological aspects and counseling best practices of introducing real-time CGM to technology-naïve patients as well as optimizing the patient’s medical management and glycemic control through the use of rtCGM.

 

Best Practices in Counseling Technology Naïve Patients and Families with the Successful Use of rtCGM

Jill Weissberg-Benchell, Ph.D., CDCES

• Professor of Psychiatry and Behavioral Medicine
• Northwestern University Feinberg School of Medicine
• Ann and Robert H. Lurie Children’s Hospital of Chicago Pritzker Department of Psychiatry and Behavioral Medicine

 

Introduction and Integration of rtCGM in the Medical Management of T1 Pediatric Patients

Anita Swamy, MD

• Medical Director and Program Co-director, Chicago Children’s Diabetes Center at La Rabida Children’s Hospital
• Attending Physician, Endocrinology Chicago Children’s Diabetes Center
• Assistant Professor of Pediatrics (Endocrinology), Northwestern University Feinberg School of Medicine

Weight management for adolescents: what are the options?

This symposium (EACCME accreditation in review) will provide education on the benefits of adjunctive therapies beyond lifestyle intervention (including counselling and pharmacotherapy) for adolescents living with obesity. The long live panel discussion will allow you to question the renowned Chair and speakers: Professors LeRoux, Murphy and Olbers

Learning objectives
Be better able to:

• Assess the underlying reasons for overweight/obesity in adolescents and its impact on psychological well-being
• Offer support/advice on weight-management strategies to adolescents living with overweight/obesity

 

13:35 – 13:45	Introduction	Carel le Roux (Chair) Professor, University College Dublin, Ireland
13:45 – 14:02	Tailoring lifestyle interventions to address psychosocial factors in adolescents	Sinead Murphy Professor, University College Dublin, Ireland
14:02 – 14:19	Further interventions for adolescents: what’s available?	Torsten Olbers Professor, Linköping University, Sweden
14:19 – 14:35	Q&As and Closing remarks

Innovations in Omnipod® Technology for the Treatment of Diabetes in the Paediatric Population

 

07:00 – 07:05	Real World Evidence of the Omnipod DASH® System in Paediatric Patients with Type 1 Diabetes	Dr Trang Ly
07:05 – 07:15	Clinical Case Review with Omnipod DASH® System in the Paediatric Population – Dr Fiona Campbell	Dr Fiona Campbell
07:15 – 07:25	The Future of Insulin Delivery Technologies in Children and Adolescents	Dr Forlenza
07:25 – 07:30	Q&As and Closing remarks

Integrated Personalised Diabetes Management: Fostering the pivotal relation between communication and technology to improve everyday therapy

The Roche Diabetes Care Symposium will focus on the importance and therapeutic value of communication in integrated Personalised Diabetes Management. The discussion will be centered around the key role it plays and how patients, caregivers and physicians interaction can be advanced. We will take a deep dive into the challenges of growing up with diabetes and how communication, particularly in remote settings can be fostered by technology, to enable optimal care and pump training in strenuous times.

 

10:25 – 10:30	Introduction	Ralph Ziegler (Germany), Thomas Künsting (Roche Diabetes Care, Germany)
10:30 – 10:45	Talk using technology Why communication is key in diabetes management and how it can be fostered by new technologies	Jill Weissberg-Benchell (US)
10:45 – 11:00	Talk in transition Challenges in handing over people from paediatric to adult healthcare	Andreas Neu (Germany)
11:00 – 11:15	Talk to train How to remotely onboard people with diabetes on their new pump in challenging times	Lesley Drummond (UK)
11:15 – 11:25	Q&As and Closing remarks

MiniMed™ 780G System: Improving Clinical Outcomes while Reducing Diabetes Management Burden

 

10:25	Introduction	Robert Vigersky
10:26 – 10:41	The Need for Technology	Tadej Battelino
10:41 – 10:58	Clinical Outcomes	Robert Vigersky
10:58 – 11:15	HCPs’ and Users’ Experience	Jennifer Sherr
11:15 – 11:25	Q&As and Closing remarks	Robert Vigersky

Successfully Initiating Automated Insulin Delivery Systems in 10-Day: In clinic & Remotely

 

06:30 – 06:05	Introduction	Ohad Cohen
06:35 – 07:15	The 10-Day Initiation Protocol: 1-Year Clinical Evidence	Goran Petrovski
	Going Virtual: Remote Initiation Protocol
07:15 – 07:30	Q&As and Closing remarks	All

Neonatal Diabetes: How to diagnose and optimize treatment

Speakers:

• Dr Rachel Williams, Cambridge University Hospital
• Prof Michel Polak, Necker Enfants Malade University Hospital Paris

Improving Time in Range with the t:slim X2 insulin pump and Control-IQ technology

Moderated by: Peter Adolfsson, MD, PhD, University of Gothenburg, Sweden

 

First Speaker: Mark Breton, PhD, University of Virginia, USA

Automated bolus and basal modulation with Control-IQ technology leads to better glycemic outcomes in adults and children

 

Second Speaker: Laya Ekhlaspour, MD, Stanford University, USA

Impact of Control-IQ technology on glycemic control for school age children with T1D

 

Third Speaker: Eric Renard, MD, PhD, University of Montpellier, France

Presentation 3 – The Free-life Kid AP Study – Control-IQ in pre-pubertal children with type 1 diabetes